Myezom 2mg Bortezomib Injection

Name: Myezom 2mg Bortezomib Injection
Brand: BHAVYA ENTERPRISES
Price: 1250 INR
Availability: InStock

Price 1250 INR/ Pack

Get a Price/Quote

MOQ : 100 Packs

Myezom 2mg Bortezomib Injection Specification

Pacakaging (Quantity Per Box)
1 vial per box

Packaging Type
Vial

Origin of Medicine
India

Salt Composition
Bortezomib

Brand Name
Myezom

Drug Type
Allopathic

Physical Form
Injection

Dosage
2 mg

Quantity
1 vial

Route
Intravenous/Subcutaneous

Strength
2mg/vial

Prescription Status
Prescription only

Solution Appearance
Lyophilized white powder

Storage
Store below 25°C

Therapeutic Class
Anti-cancer

Hospital Use
Yes

Myezom 2mg Bortezomib Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Myezom 2mg Bortezomib Injection

Order Today and take advantage of the Reduced Price on the grandiose Myezom 2mg Bortezomib Injection, a superior anti-cancer medication for hospital use. This radiant solution, presented in a lyophilized white powder, offers advance purchase opportunities for oncology departments seeking consistent supply. Crafted in India with allopathic precision, each vial delivers a potent 2mg dosage for intravenous or subcutaneous administration. Myezom ensures therapeutic excellence, requiring refrigeration below 25C for safety. Trust in its superior efficacy and secure your supply now for optimal patient outcomes.

Key Features and Clinical Applications

Myezom 2mg Bortezomib Injection exhibits superior material quality with its lyophilized white powder form, ensuring optimal stability. Specifically intended for intravenous and subcutaneous administration, it is used as a frontline or adjunctive anti-cancer agent, expertly formulated for hospital oncology settings. Prescription-only status guarantees that it is dispensed by qualified healthcare professionals, supporting precise dosage control and effectiveness in combatting multiple myeloma and other malignancies.

Packaging, Distribution, and Domestic Reach

Myezom 2mg Bortezomib Injection is outlaid in a single vial per box, supporting secure shipment and ease of inventory management. The robust packaging upholds the product's quality throughout domestic mar logistics. With consistent supply ability and reliable delivery timelines, healthcare institutions across India's main domestic market can trust timely procurement and seamless incorporation into their therapeutic regimens, ensuring patient care is never compromised.

FAQ's of Myezom 2mg Bortezomib Injection:

Q: How should Myezom 2mg Bortezomib Injection be stored to preserve its efficacy?

A: Myezom 2mg Bortezomib Injection should be stored below 25C in its original packaging to maintain its lyophilized integrity and therapeutic potency.

Q: What is the process for ordering Myezom 2mg at a reduced price for hospital use?

A: Hospitals can request advance purchase and bulk order options from the supplier or trader to access reduced pricing. Orders are typically processed directly with supporting documentation, given its prescription-only status.

Q: When is Myezom 2mg Bortezomib Injection used in therapy?

A: Myezom 2mg is primarily used in anti-cancer protocols, often as a first-line or adjunctive treatment for multiple myeloma and similar malignancies, as prescribed by an oncologist.

Q: Where is Myezom 2mg Bortezomib Injection manufactured and supplied from?

A: Myezom 2mg is developed and packaged in India and is widely distributed through domestic supply channels for hospital and clinical use.

Q: What are the distinct material features of Myezom 2mg Bortezomib Injection?

A: It features a lyophilized white powder form, ensuring a stable and pure solution for intravenous or subcutaneous use in controlled medical environments.

Q: How can healthcare providers benefit from advance purchasing of Myezom 2mg?

A: Advance purchase allows healthcare institutions to secure their supply at a reduced price, ensuring consistent treatment availability for patients requiring anti-cancer therapy.

Tell us about your requirement